Insys Therapeutics, Inc. et al v. Teva Pharmaceuticals USA, Inc.
Plaintiff: Insys Development Company, Inc. and Insys Therapeutics, Inc.
Defendant: Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Case Number: 1:2018cv01308
Filed: August 23, 2018
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on September 27, 2018. A more recent docket listing may be available from PACER.

Date Filed Document Text
September 27, 2018 Opinion or Order Filing 15 CONSOLIDATION AND SCHEDULING ORDER: Teva Pharmaceutical Industries, Ltd. is dismissed. THESE CASES ARE CONSOLIDATED FOR ALL PURPOSES AND ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 17-1303-CFC. Joinder of Parties due by 9/27/2018. Claim Construction Opening Brief Served by 11/6/2018. Claim Construction Answering Brief Served by 12/3/2018. Claim Construction Reply Brief Served by 12/21/2018. Claim Construction Surreply Brief Served by 1/8/2019. Parties to File Joint Claim Construction Brief & Joint Appendix of Evidence by 1/11/2019. A Markman Hearing is set for 2/12/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 9/9/2019. A Final Pretrial Conference is set for 9/23/2019 at 10:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 10/15/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/26/2018. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf)
September 27, 2018 Case associated with lead case: Create association to 1:17-cv-01303-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 17-1303-CFC ONLY. (nmf)
September 24, 2018 Filing 14 Joint STIPULATION and [Proposed] Order to Consolidate Actions and Dismiss Teva Pharmaceutical Industries Ltd. by Insys Development Company, Inc., Insys Therapeutics, Inc.. (Ying, Jennifer)
September 19, 2018 Filing 13 ANSWER to #6 Answer to Complaint, Counterclaim -- Answer to Counterclaim -- by Insys Development Company, Inc., Insys Therapeutics, Inc..(Blumenfeld, Jack)
September 18, 2018 Minute Entry for proceedings held before Judge Colm F. Connolly - Telephonic Scheduling Conference held on 9/18/2018. (Court Reporter V. Gunning.) Counsel to submit a revised stipulation regarding scheduling and consolidation to the Court. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf)
September 17, 2018 Filing 12 NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd..(Shaw, John)
September 13, 2018 Opinion or Order Filing 11 Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 9/18/2018 at 02:00 PM before Judge Colm F. Connolly to discuss the parties' proposed modifications to the case schedule as outlined in the stipulation of September 11, 2018. Counsel for plaintiffs shall coordinate and initiate the call to chambers. Signed by Judge Colm F. Connolly on 9/13/2018. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(nmf)
September 12, 2018 Opinion or Order Filing 10 ORAL ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 2/26/2019 at 10:00 AM Eastern Time before Judge Mary Pat Thynge to discuss the status of the matters and ADR. Ordered by Judge Mary Pat Thynge on 9/12/18. Associated Cases: 1:17-cv-01303-CFC, 1:18-cv-00414-CFC, 1:18-cv-01308-CFC(cak)
September 11, 2018 Filing 9 STIPULATION [And [Proposed] Order To Consolidate Actions And Dismiss Teva Pharmaceutical Industries, Ltd by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 9/11/2018 (mdb).
August 29, 2018 Filing 8 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceuticals USA, Inc. for Teva Pharmaceutical Industries Ltd. filed by Teva Pharmaceutical Industries Ltd.. (Hoeschen, Nathan)
August 29, 2018 Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan)
August 29, 2018 Filing 6 ANSWER to #1 Complaint, , COUNTERCLAIM against Insys Development Company, Inc., Insys Therapeutics, Inc. by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan)
August 29, 2018 Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
August 24, 2018 Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd. on 8/24/2018; Teva Pharmaceuticals USA, Inc. on 8/24/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb)
August 23, 2018 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Insys Therapeutics, Inc. for Insys Development Company, Inc. filed by Insys Development Company, Inc., Insys Therapeutics, Inc. (crb)
August 23, 2018 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,972 B2 ;8,486,973 B2 ;8,835,459 B2 ;8,835,460 B2 ;9,241,935 B2. (crb)
August 23, 2018 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/10/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 7/31/2020. (crb)
August 23, 2018 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb)
August 23, 2018 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2446245.) - filed by Insys Therapeutics, Inc., Insys Development Company, Inc. (Attachments: #1 Exhibit A - H, #2 Civil Cover Sheet)(crb) (Main Document 1 replaced on 8/27/2018) (nmg).

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Insys Therapeutics, Inc. et al v. Teva Pharmaceuticals USA, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Insys Development Company, Inc.
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Insys Therapeutics, Inc.
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals USA, Inc.
Represented By: Nathan Roger Hoeschen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceutical Industries Ltd.
Represented By: Nathan Roger Hoeschen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?